Jatin Patel

Jatin Patel has a significant work experience in the pharmaceutical industry. Jatin is currently the Senior Vice President and Head of CMC at Constellation Pharmaceuticals, a MorphoSys Company, a role they started in September 2022. Before this, they worked as the Vice President of Drug Product Development & Technical Operations at the same company from July 2020 to September 2022. In this position, they built the Drug Product Development & Technical Operations function and was responsible for various vendor relationships, drug product and analytical development, establishment of clinical and commercial supply chain, and executing technical operations activities.

Prior to joining Constellation Pharmaceuticals, Jatin Patel had various roles at Bristol-Myers Squibb. From 2015 to 2018, they served as the Head of Oral Product Design & Development. Jatin also held multiple positions in the company between 1991 and 2014, including Head of Exploratory Pharmaceutical Sciences and CMC Program Lead for Eliquis.

Additionally, Jatin Patel worked as a Director in Exploratory Pharmaceutical Sciences and Director of Portfolio Enablement Technologies at Bristol-Myers Squibb from 2009 to 2011 and 2009 respectively.

Jatin Patel's career in the pharmaceutical industry started at the University of Iowa where they worked as a Graduate Student from 1986 to 1991.

Jatin Patel obtained a Bachelor's degree in Pharmacy from Maharaja SayajiRao University, where they studied from 1981 to 1985. Jatin then pursued a Ph.D. in Pharmaceutics at the University of Iowa, completing their studies from 1986 to 1991. Prior to their university education, Jatin attended Vidyakunj High School from 1977 to 1981. No degree or field of study is mentioned for this period.